APAC Beauty-from-Within Market Shifts: Localisation, Personalisation Drive New Growth Beyond Aesthetics

Singapore, Singapore — 15 April 2024

The Asia Pacific (APAC) beauty-from-within sector is undergoing a significant transformation, moving beyond purely aesthetic concerns to embrace holistic health, self-awareness, and personal well-being. SuanNutra, a key ingredient supplier, identifies substantial growth opportunities in localised, personalised, and life-stage-specific innovations, despite the perceived dominance of established Korean and Japanese brands. The evolving consumer perception, influenced by pop culture and a global body positivity movement, increasingly prioritises health, freedom, and self-acceptance as components of beauty.

Regional nuances are critical for market penetration. Japan emphasises natural and holistic care, China focuses on freedom and independence, while South Korea gravitates towards health and well-being. Ignacio Cartagena, Vice President of SuanNutra Asia Division, asserts that these markets are far from saturated, representing cornerstones for strategic growth. Korean products leverage cutting-edge technology and natural science, while Japanese skincare remains rooted in tradition, focusing on holistic skin health. Developing differentiated and valuable propositions for each customer type is paramount for market success.

A significant trend is the demand for personalisation, addressing specific needs often considered taboo or underserved. This includes solutions for menopause, ageing, and male-specific beauty supplements. Consumers aged 45 and above currently account for 33% of the total spending in this segment across APAC, with projections to exceed 41% by 2040. This demographic drives high demand for ingredients that support menopausal women or mitigate skin ageing effects. Firms like SuanNutra are employing AI to understand ingredient efficacy across diverse population segments and plan to launch two new branded products annually, backed by clinical research.

Hair and scalp wellness presents another high-growth area. The APAC hair loss treatment market reached approximately USD700 million in retail sales value in 2023, exhibiting a 14% compound annual growth rate (CAGR) between 2018 and 2023. This growth is fuelled by younger consumers facing premature hair thinning and loss due to modern lifestyles. While Minoxidil remains a dominant active ingredient, demand for other ingredients and preventative treatments is accelerating. Additionally, while collagen maintains its position as a leading ingredient, alternative options like mushrooms, botanical extracts, omegas, and probiotics are gaining traction among Asian consumers.

What this means for Singapore

Singaporean manufacturers and brand owners must prioritise clinical substantiation and targeted product development. Reformulation windows should focus on ingredients addressing specific life-stage concerns (e.g., menopause, male beauty) and hair/scalp health, leveraging rising consumer awareness. Procurement teams should secure supply chains for clinically backed ingredients like SuanNutra's Nutroxsun or Zeropollution, which have demonstrated efficacy in regional populations. Brands differentiating with hyper-personalised, data-driven solutions will gain competitive advantage. Compliance teams must navigate varying health claims approvals across APAC, such as those obtained by SuanNutra for Nutroxsun and MetabolAid in Korea, impacting market entry strategies and marketing claims.

This trend is being actively addressed by UK manufacturing partners including Supplement Factory.